Granules India Limited

Granules India Limited (GRANULES) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

granulesindia.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹853.85
Market cap
21,165 Cr
Stock P/E
31.0
P/B
4.11
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales1,189 Cr1,156 Cr1,176 Cr1,180 Cr967 Cr1,138 Cr1,197 Cr1,210 Cr1,297 Cr1,388 Cr1,471 Cr1,477 Cr
Operating expenses (approx.)977 Cr905 Cr920 Cr921 Cr763 Cr907 Cr945 Cr963 Cr1,019 Cr1,080 Cr1,119 Cr1,138 Cr
EBITDA213 Cr250 Cr256 Cr259 Cr203 Cr230 Cr252 Cr247 Cr278 Cr308 Cr352 Cr339 Cr
OPM %17.9%21.7%21.7%22.0%21.0%20.2%21.1%20.4%21.5%22.2%23.9%22.9%
Other income2 Cr0.65 Cr2 Cr2 Cr3 Cr6 Cr2 Cr16 Cr-1 Cr-4 Cr9 Cr2 Cr
Interest26 Cr29 Cr29 Cr27 Cr26 Cr27 Cr24 Cr24 Cr29 Cr29 Cr33 Cr21 Cr
Depreciation53 Cr52 Cr53 Cr53 Cr53 Cr57 Cr63 Cr69 Cr72 Cr74 Cr82 Cr80 Cr
Profit before tax136 Cr170 Cr176 Cr181 Cr128 Cr153 Cr198 Cr145 Cr176 Cr202 Cr262 Cr240 Cr
Tax %24.9%26.1%26.2%25.8%24.3%23.0%23.0%22.1%25.7%25.7%23.2%25.1%
Net profit102 Cr126 Cr130 Cr135 Cr97 Cr118 Cr152 Cr113 Cr131 Cr150 Cr202 Cr180 Cr
EPS (₹)₹4.22₹5.18₹5.35₹5.56₹4.01₹4.85₹6.27₹4.64₹5.38₹6.19₹8.23₹7.26

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,279 Cr2,599 Cr3,238 Cr3,765 Cr4,512 Cr4,506 Cr4,482 Cr5,366 CrSign in for TTM
Operating expenses (approx.)1,895 Cr2,073 Cr2,382 Cr3,043 Cr3,598 Cr3,650 Cr3,536 Cr4,180 CrSign in for TTM
EBITDA384 Cr525 Cr855 Cr722 Cr914 Cr856 Cr945 Cr1,185 CrSign in for TTM
OPM %16.8%20.2%26.4%19.2%20.3%19.0%21.1%22.1%Sign in for TTM
Other income27 Cr37 Cr27 Cr18 Cr14 Cr4 Cr13 Cr20 CrSign in for TTM
Interest28 Cr27 Cr26 Cr23 Cr56 Cr106 Cr103 Cr114 CrSign in for TTM
Depreciation105 Cr137 Cr151 Cr159 Cr184 Cr207 Cr226 Cr296 CrSign in for TTM
Profit before tax326 Cr451 Cr704 Cr558 Cr687 Cr547 Cr660 Cr785 CrSign in for TTM
Tax %27.4%25.7%22.0%26.0%24.8%25.9%24.0%24.2%Sign in for TTM
Net profit236 Cr335 Cr549 Cr413 Cr517 Cr405 Cr502 Cr595 CrSign in for TTM
EPS (₹)₹9.30₹13.19₹22.05₹16.66₹21.05₹16.73₹20.69₹24.47Sign in for TTM
Dividend payout %———9.0%3.6%9.0%7.2%6.1%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital25 Cr25 Cr25 Cr25 Cr24 Cr24 Cr24 Cr25 Cr
Reserves1,504 Cr1,818 Cr2,149 Cr2,562 Cr2,811 Cr3,201 Cr3,691 Cr5,060 Cr
Borrowings933 Cr793 Cr750 Cr1,093 Cr1,059 Cr1,223 Cr1,286 Cr1,338 Cr
Other liabilities520 Cr665 Cr790 Cr833 Cr1,011 Cr1,072 Cr1,251 Cr1,297 Cr
Total liabilities2,983 Cr3,301 Cr3,713 Cr4,513 Cr4,905 Cr5,521 Cr6,253 Cr7,720 Cr
Fixed assets (net)748 Cr989 Cr1,071 Cr1,284 Cr1,631 Cr1,856 Cr2,217 Cr3,051 Cr
CWIP323 Cr148 Cr185 Cr312 Cr228 Cr260 Cr437 Cr406 Cr
Investments210 Cr19 Cr19 Cr20 Cr21 Cr22 Cr22 Cr0.84 Cr
Loans & advances3 Cr8 Cr10 Cr8 Cr0 Cr0 Cr0 Cr0 Cr
Inventories384 Cr438 Cr782 Cr979 Cr1,149 Cr1,301 Cr1,343 Cr1,673 Cr
Trade receivables674 Cr735 Cr765 Cr925 Cr949 Cr986 Cr942 Cr909 Cr
Cash & bank83 Cr186 Cr42 Cr185 Cr292 Cr381 Cr466 Cr880 Cr
Other assets557 Cr778 Cr839 Cr802 Cr634 Cr716 Cr825 Cr799 Cr
Total assets2,983 Cr3,301 Cr3,713 Cr4,513 Cr4,905 Cr5,521 Cr6,253 Cr7,720 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———332 Cr739 Cr439 Cr867 Cr793 Cr
Cash from investing———-380 Cr-191 Cr-360 Cr-691 Cr-773 Cr
Cash from financing———190 Cr-440 Cr8 Cr-93 Cr379 Cr
Net cash flow———143 Cr107 Cr90 Cr85 Cr412 Cr
Free cash flow (OCF − Capex)———-66 Cr328 Cr59 Cr295 Cr235 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %23.1%25.9%33.6%22.5%19.1%14.7%15.3%14.0%
ROE %0.0%0.0%25.3%16.0%18.2%13.2%13.5%11.7%
Debtor days108103868977807762
Inventory days104122179175178215283290
Days payable88119124114121124153117
Cash conversion cycle124106141150133171207235
Debt / equity0.000.000.000.420.370.380.350.26
Current ratio1.431.651.701.531.421.401.561.80
Net debt / EBITDA0.000.000.000.000.840.980.870.39

Compare with peers

Loading peers…